Inventor

WARNER STEVEN L

US36 patents

⚠️ This page may combine multiple inventors who share the name “WARNER STEVEN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WARNER STEVEN L

TOLERO PHARMACEUTICALS INC

Predicting response to alvocidib by mitochondrial profiling

Profiling peptides and methods for sensitivity profiling

Profiling peptides and methods for sensitivity profiling

Combination therapies for treatment of cancer

Predicting response to alvocidib by mitochondrial profiling

Combination therapies for treatment of cancer

Predicting response to alvocidib by mitochondrial profiling

JAK2 and ALK2 inhibitors and methods for their use

Profiling peptides and methods for sensitivity profiling

JAK1 and ALK2 inhibitors and methods for their use

SUMITOMO PHARMA ONCOLOGY INC

Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib

Formulations comprising heterocyclic protein kinase inhibitors

Compositions comprising PKM2 modulators and methods of treatment using the same

AXL kinase inhibitors and use of the same

Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

ALK-5 inhibitors and uses thereof

UNIV UTAH RES FOUND

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

UNIV ARIZONA

Substituted tricyclic compounds as protein kinase inhibitors

Substituted tricyclic compounds as protein kinase inhibitors

Substituted tricyclic compound as protein kinase inhibitors

Substituted tricyclic compounds as protein kinase inhibitors

BEARSS DAVID J

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase

Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC

Combination therapies for treatment of cancer

Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same

MANNKIND CORP

Multiple kinase pathway inhibitors

Multiple kinase pathway inhibitors

VANKAYALAPATI HARIPRASAD

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

UNIV ARIZONA STATE

Protein kinase inhibitors

HURLEY LAURENCE H

Substituted tricyclic compounds as protein kinase inhibitors